Advancements in Aggressive Non-Hodgkin Lymphomas (NHL)
November 19, 2024
Replay will be available soon.
Topics Covered
We invite you to learn more about:
- How your NHL subtype determines treatment goals and strategies
- Current and emerging therapies for aggressive subtypes of NHL
- Methods to manage side effects
- The importance of discussing quality-of-life issues with your healthcare team
Program Materials
Transcript will be available soon.
Speaker
Joshua Brody, MD
Director, Lymphoma Immunotherapy Program
Icahn School of Medicine at Mount Sinai
Hess Center for Science and Medicine
New York, NY
Program Support
Support for this program provided by Genentech, a member of the Roche Group.